PRODUCTS

INTERNATIONAL  /  REPAGLINIDE «  BACK TO "INTERNATIONAL"

Repaglinide is a carbamoylmethyl benzoic acid derivative, which lowers the blood glucose levels acutely by stimulating the release of insulin from the pancreas.

Repaglinide is indicated in patients with Type II diabetes.

Active ingredient Pharmaceutical form Package Therapeutic target
  • Repaglinide
  • Tablets
  • 0.5mg
  • 1mg
  • 2mg
  • Diabetes Type II

Other products in "International"